Pegasys Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent
Condition:   Chronic Viral Hepatitis B With Delta-agent Interventions:   Drug: Myrcludex B;   Drug: PEG IFN alfa-2a Sponsor:   Hepatera Ltd. Active, not recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 30, 2016 Category: Research Source Type: clinical trials